[Status of cellular immunity in patients with Astrakhan fever].

Autor:	Kasimova NB, Kulikova IN, Karpenko SF, Burkin VS, Altukhov SA, Arshba TE, Aĭrapetova GS
Jazyk:	ruština
Zdroj:	Terapevticheskii arkhiv [Ter Arkh] 2002; Vol. 74 (11), pp. 23-6.
Abstrakt:	Aim: To ascertain regularities of development of cellular immunity in patients with Astrakhan fever (AF) with reference to AF severity, treatment and course. Material and Methods: Cellular factors of immunity--relative and absolute contents of T-lymphocytes (early and late), T-helpers and T-suppressors, B-lymphocytes, neutrophils (early and late)--were studied in 75 patients with AF (63 patients with moderate and 12 patients with severe disease) in the course of the disease progression (weeks 1-5). The patients received antibacterial treatment--doxicyclin, rifampicin and doxicycline in combination with alpha 2-realdiron and gamma-reaferon. Results: Examination of immunocompetent cells has revealed suppression of T- and B-immunity for 2 weeks in moderate AF and 3 weeks in severe AF. The number of T-helpers was low for 3 weeks while of T-suppressors rose beginning from week 2. Immunoregulatory index Tx/Tc remains low till the end of the disease. The number of early and late neutrophils increased since weeks 2 of the disease in moderate and week 3 in severe AF. Conclusion: Doxicycline efficiency was higher than that of rifampicin. Interferon preparations decrease relative number of early and late T-lymphocytes, neutrocytes and T-helpers but their absolute number is at the control level. Relative content of T-suppressors and B-lymphocytes is as in controls but their absolute content is higher.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu